Legal & General Group PLC Personalis, Inc. Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$3.27 - $8.76 $72,165 - $193,324	-22,069 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.24 - $21.25 $100,465 - $174,420	8,208 Added 59.22%	22,069 $315,000
Q3 2021 Nov 15, 2021	BUY	$16.69 - $26.05 $108,101 - $168,725	6,477 Added 87.72%	13,861 $268,000
Q2 2021 Aug 12, 2021	BUY	$18.15 - $27.75 $9,782 - $14,957	539 Added 7.87%	7,384 $186,000
Q1 2021 May 17, 2021	BUY	$20.71 - $51.02 $911 - $2,244	44 Added 0.65%	6,845 $169,000
Q4 2020 Feb 12, 2021	BUY	$21.84 - $44.0 $86,748 - $174,768	3,972 Added 140.4%	6,801 $249,000
Q3 2020 Nov 13, 2020	SELL	$13.63 - $24.12 $5,220 - $9,237	-383 Reduced 11.92%	2,829 $61,000
Q2 2020 Aug 14, 2020	BUY	$7.65 - $14.11 $3,932 - $7,252	514 Added 19.05%	3,212 $42,000
Q1 2020 May 14, 2020	BUY	$4.75 - $12.41 $4,436 - $11,590	934 Added 52.95%	2,698 $22,000
Q4 2019 Feb 13, 2020	BUY	$8.73 - $12.95 $2,496 - $3,703	286 Added 19.35%	1,764 $19,000
Q3 2019 Nov 13, 2019	BUY	$14.16 - $25.34 $20,928 - $37,452	1,478 New	1,478 $22,000

112

30.1M

10.9K

87.8K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $253M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.